Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rainmed MedicalHKSE:02297 -1.27%50 Gross Margin % is 44.72% as of Dec. 2025, which is 40% below its 10-year median of 74.92. GuruFocus rates HKSE:02297 with a GF Score™ of 50/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Rainmed Medical ranks worse than 57.52% on this metric.
Rainmed Medical Ltd gross margin has been in long-term decline. The average rate of decline per year is -11.6%.
The historical rank and industry rank for Rainmed Medical's Gross Margin % or its related term are showing as below:
HKSE:02297'
s Gross Margin % Range Over the Past 10 Years
Min: 47.13 Med: 74.92 Max: 86.26
Current: 47.13
During the past 6 years, the highestGross Margin % of Rainmed Medical was 86.26%. The lowest was 47.13%. And the median was 74.92%.
HKSE:02297's Gross Margin % is ranked worse than 57.52% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.16
vs HKSE:02297: 47.13
Rainmed Medical had a gross margin of 44.72% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Rainmed Medical was -11.60% per year.
Rainmed Medical (HKSE:02297) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Rainmed Medical had a gross margin of 44.72% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Rainmed Medical Gross Margin % Related Terms
Rainmed Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Rainmed Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02297 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Rainmed Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainmed Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Rainmed Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Rainmed Medical (HKSE:02297) has a Gross Margin % of 44.72% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Rainmed Medical and its competitors. This is 40% below median its historical median of 74.92. Over the past decade, Rainmed Medical's Gross Margin % has ranged from 47.13 to 86.26. According to the industry distribution chart, Rainmed Medical ranks #463 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 57.5%.
Is Rainmed Medical's Gross Margin % too high?
Rainmed Medical's current Gross Margin % of 44.72% is 40% below median its 10-year median of 74.92. Over the past 10 years, this metric has ranged from a low of 47.13 to a high of 86.26. The Medical Devices & Instruments industry median Gross Margin % is 52.16. Rainmed Medical's value of 44.72% is 14.3% below this industry median. Based on the distribution chart, Rainmed Medical ranks #463 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Rainmed Medical has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rainmed Medical's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rainmed Medical ranks #463 out of 805 companies for Gross Margin %. This places Rainmed Medical in the lower half of its industry. The industry median Gross Margin % is 52.16. Rainmed Medical's value of 44.72% is 14.3% below this benchmark. Historically, Rainmed Medical's own Gross Margin % has ranged from 47.13 to 86.26 over the past decade. While the company's 10-year median is 74.92 vs. the industry median of 52.16, Rainmed Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.16, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rainmed Medical's current Gross Margin % of 44.72% is 14.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Rainmed Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainmed Medical's current Gross Margin % is 44.72%, which is 40% below median its own 10-year median of 74.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainmed Medical stock overvalued right now?
Based on GuruFocus' analysis, Rainmed Medical (HKSE:02297) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.23 — trading 192.5% above its estimated fair value. The current Gross Margin % is 44.72%, which is 40% below median its 10-year median of 74.92 and 14.3% below the Medical Devices & Instruments industry median of 52.16. Rainmed Medical's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Rainmed Medical (HKSE:02297), the current Gross Margin % is 44.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainmed Medical (HKSE:02297) Overvalued in 2026?
Based on GuruFocus' analysis, Rainmed Medical stock appears to be overvalued.
The current stock price of HK$0.23 is trading 192.5% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Rainmed Medical to be Significantly Overvalued.
Key valuation signals for HKSE:02297:
Gross Margin %: 44.72% (40% below median its 10-year median of 74.92)
GF Value™: HK$0.08 vs. price of HK$0.23 (192.5% above fair value)
Industry Position: 14.3% below the Medical Devices & Instruments median (#463 of 805)
No single metric tells the full story. See the HKSE:02297 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
50GF Score
Get the complete analysis for HKSE:02297
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02297 has been successfully added to your 
